INHIBITION OF CONSTITUTIVELY ACTIVE STAT3 REVERSES ENZALUTAMIDE RESISTANCE IN LNCAP DERIVATIVE PROSTATE CANCER CELLS

被引：0
|
作者：
Liu, Chengfei
Zhu, Yezi
Lou, Wei
Cui, Yuanyuan
Evans, Christopher P.
Gao, Allen C.
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.289
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP24-08
引用
收藏
页码：E262 / E262
页数：1
相关论文
共 50 条
  • [31] STAT3 as a target for sensitizing prostate cancer cells to irradiation
    Zhang, Qu
    Zhou, Xiao-Mei
    Wei, Shao-Zhong
    Cui, Dian-Sheng
    Deng, Kang-Li
    Liang, Gai
    Luo, Yan
    Luo, Bo
    Liang, Xin-Jun
    JOURNAL OF RADIATION RESEARCH, 2022, 63 (02) : 174 - 182
  • [32] Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways
    Wang, Yongzhi
    Chen, Lingchao
    Bao, Zhaoshi
    Li, Shouwei
    You, Gan
    Yan, Wei
    Shi, Zhendong
    Liu, Yanwei
    Yang, Pei
    Zhang, Wei
    Han, Lei
    Kang, Chunsheng
    Jiang, Tao
    ONCOLOGY REPORTS, 2011, 26 (05) : 1173 - 1180
  • [33] STAT3 is constitutively active in some patients with polycythemia vera.
    Roeder, S
    Pahl, HL
    BLOOD, 1999, 94 (10) : 113A - 113A
  • [34] Cyclanoline Reverses Cisplatin Resistance in Bladder Cancer Cells by Inhibiting the JAK2/STAT3 Pathway
    Li, Linjin
    Li, Chengpeng
    Miao, Feilong
    Chen, Wu
    Kong, Xianghui
    Ye, Ruxian
    Wang, Feng
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024, 24 (18) : 1360 - 1370
  • [35] STAT3 is constitutively active in some patients with Polycythemia rubra vera
    Röder, S
    Steimle, C
    Meinhardt, G
    Pahl, HL
    EXPERIMENTAL HEMATOLOGY, 2001, 29 (06) : 694 - 702
  • [36] Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
    Daksh Thaper
    Sepideh Vahid
    Ramandeep Kaur
    Sahil Kumar
    Shaghayegh Nouruzi
    Jennifer L. Bishop
    Martin Johansson
    Amina Zoubeidi
    Scientific Reports, 8
  • [37] Galiellalactone inhibits the STAT3/AR signaling axis and suppresses Enzalutamide-resistant Prostate Cancer
    Thaper, Daksh
    Vahid, Sepideh
    Kaur, Ramandeep
    Kumar, Sahil
    Nouruzi, Shaghayegh
    Bishop, Jennifer L.
    Johansson, Martin
    Zoubeidi, Amina
    SCIENTIFIC REPORTS, 2018, 8
  • [38] Galiellalactone derivative targets stem cell population in ENZ-resistant prostate cancer through inhibition of STAT3
    Vahid, Sepideh
    Thaper, Daksh
    Davies, Alistair
    Van Rensburg, Micaela Janse
    Gibson, Kate
    Ketola, Krisi
    Johansson, Martin
    Bishop, Jennifer L.
    Zoubeidi, Amina
    CANCER RESEARCH, 2016, 76
  • [39] Acute myeloid leukemia cells contain constitutively activated STAT3 and require STAT3 for survival.
    Kim, TK
    Carroll, M
    Gewirtz, AM
    BLOOD, 2004, 104 (11) : 919A - 920A
  • [40] Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells
    Goode, Emily Archer
    Orozco-Moreno, Margarita
    Hodgson, Kirsty
    Nabilah, Amirah
    Murali, Meera
    Peng, Ziqian
    Merx, Jona
    Rossing, Emiel
    Pijnenborg, Johan F. A.
    Boltje, Thomas J.
    Wang, Ning
    Elliott, David J.
    Munkley, Jennifer
    CANCERS, 2024, 16 (17)
12345